+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Viscosupplementation Devices - Medical Devices Pipeline Assessment, 2020

  • ID: 5230851
  • Report
  • December 2020
  • Region: Global
  • 55 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Ampio Pharmaceuticals Inc
  • Carticept Medical Inc
  • Cocoon Biotech, Inc.
  • Herng Shan Co Ltd
  • Medytox Inc
  • OPKO Health Inc
  • MORE
Summary

The publisher's Medical Devices sector report, “Viscosupplementation Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Viscosupplementation Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Viscosupplementation is the process by which the synovial fluid at the joints is replaced by an Hyaluronate preparation which has viscous properties similar to the natural synovial fluid.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Viscosupplementation Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Viscosupplementation Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Viscosupplementation Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Ampio Pharmaceuticals Inc
  • Carticept Medical Inc
  • Cocoon Biotech, Inc.
  • Herng Shan Co Ltd
  • Medytox Inc
  • OPKO Health Inc
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Viscosupplementation Overview

3 Products under Development
3.1 Viscosupplementation - Pipeline Products by Stage of Development
3.2 Viscosupplementation - Pipeline Products by Segment
3.3 Viscosupplementation - Pipeline Products by Territory
3.4 Viscosupplementation - Pipeline Products by Regulatory Path
3.5 Viscosupplementation - Pipeline Products by Estimated Approval Date
3.6 Viscosupplementation - Ongoing Clinical Trials

4 Viscosupplementation - Pipeline Products under Development by Companies
4.1 Viscosupplementation Companies - Pipeline Products by Stage of Development
4.2 Viscosupplementation - Pipeline Products by Stage of Development

5 Viscosupplementation Companies and Product Overview
5.1 Ampio Pharmaceuticals Inc Company Overview
5.1.1 Ampio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Anika Therapeutics Inc Company Overview
5.2.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Carticept Medical Inc Company Overview
5.3.1 Carticept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Chi2Gel Ltd. Company Overview
5.4.1 Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.5 Cocoon Biotech, Inc. Company Overview
5.5.1 Cocoon Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.6 Flex Biomedical Inc Company Overview
5.6.1 Flex Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Herng Shan Co Ltd Company Overview
5.7.1 Herng Shan Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.8 Kalvista Pharmaceuticals Inc Company Overview
5.8.1 Kalvista Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 KiOmed Pharma Company Overview
5.9.1 KiOmed Pharma Pipeline Products & Ongoing Clinical Trials Overview
5.10 Lineage Cell Therapeutics Inc Company Overview
5.10.1 Lineage Cell Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Medytox Inc Company Overview
5.11.1 Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Moebius Medical Ltd Company Overview
5.12.1 Moebius Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.13 OPKO Health Inc Company Overview
5.13.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Shin Poong Pharm Co Ltd Company Overview
5.14.1 Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.15 University of Kansas Company Overview
5.15.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview

6 Viscosupplementation- Recent Developments
6.1 Jun 29, 2020: DePuy Synthes renews cooperation agreement with AO Foundation to continue advancement of surgical education
6.2 Apr 08, 2020: Anika takes actions to strengthen liquidity in light of covid-19
6.3 Apr 06, 2020: New Jersey Chiropractor agrees to pay $2 million to resolve allegations of unnecessary knee injections and knee braces and related kickbacks
6.4 Feb 04, 2020: Seikagaku: Consolidated financial results for the first nine months of fiscal 2019
6.5 Dec 18, 2019: Bioventus to provide Blue Cross Blue Shield of Michigan with preferred options for knee osteoarthritis patients
6.6 Dec 03, 2019: KalVista Pharmaceuticals reports fiscal second quarter results
6.7 Dec 02, 2019: Fidia Introduces in the US the 3-injection regimen TRILURON (sodium hyaluronate)

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Viscosupplementation - Pipeline Products by Stage of Development
Table 2: Viscosupplementation - Pipeline Products by Segment
Table 3: Viscosupplementation - Pipeline Products by Territory
Table 4: Viscosupplementation - Pipeline Products by Regulatory Path
Table 5: Viscosupplementation - Pipeline Products by Estimated Approval Date
Table 6: Viscosupplementation - Ongoing Clinical Trials
Table 7: Viscosupplementation Companies - Pipeline Products by Stage of Development
Table 8: Viscosupplementation - Pipeline Products by Stage of Development
Table 9: Ampio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Ampion - Product Status
Table 11: Ampion - Product Description
Table 12: Ampion - Hand Osteoarthritis - Product Status
Table 13: Ampion - Hand Osteoarthritis - Product Description
Table 14: Ampio Pharmaceuticals Inc - Ongoing Clinical Trials Overview
Table 15: Ampion - A Randomized, Controlled, Double-blind Study to Evaluate the Efficacy and Safety of an Intra-articular Injection of Ampion in Adults with Pain Due to Severe Osteoarthritis of the Knee
Table 16: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Cingal - Product Status
Table 18: Cingal - Product Description
Table 19: Hyaluronic Acid - Synovial Joints - Product Status
Table 20: Hyaluronic Acid - Synovial Joints - Product Description
Table 21: MONOVISC - Hip - Product Status
Table 22: MONOVISC - Hip - Product Description
Table 23: ORTHOVISC-T - Product Status
Table 24: ORTHOVISC-T - Product Description
Table 25: Sodium Hyaluronate - Osteoarthritis - Product Status
Table 26: Sodium Hyaluronate - Osteoarthritis - Product Description
Table 27: Anika Therapeutics Inc - Ongoing Clinical Trials Overview
Table 28: Cingal - A Prospective Evaluation of the Cingal Injection for Hip Osteoarthritis (ECHO Study)
Table 29: Cingal - A Prospective Study of a Single Injection Cross-linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (CINGAL) to Provide Symptomatic Relief of Osteoarthritis of Ankle Joint
Table 30: MONOVISC - Hip - A Prospective Study of a Single Injection Cross-linked Sodium Hyaluronate (Monovisc) to Provide Symptomatic Relief of Osteoarthritis of Hip Joint
Table 31: MONOVISC - Hip - Investigational Device Exemption (IDE) Phase III Study of MONOVISC to Treat Pain Caused by Osteoarthritis of the Hip
Table 32: ORTHOVISC-T - A Prospective, Open-label, Multi-center Post-market Clinical Follow-up Study to Evaluate the Residual Risk of OrthoVisc-T (OVT) in the Treatment of Chronic Lateral Epicondylosis (Tennis Elbow)
Table 33: Carticept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Agilus - Product Status
Table 35: Agilus - Product Description
Table 36: Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Chi2Knee - Product Status
Table 38: Chi2Knee - Product Description
Table 39: Cocoon Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Silk Hydrogel - Product Status
Table 41: Silk Hydrogel - Product Description
Table 42: Flex Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Flex Polymer - Product Status
Table 44: Flex Polymer - Product Description
Table 45: Herng Shan Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Hyalease 16 and 20 - Product Status
Table 47: Hyalease 16 and 20 - Product Description
Table 48: Hyalease 8 - Product Status
Table 49: Hyalease 8 - Product Description
Table 50: Kalvista Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

List of Figures
Figure 1: Viscosupplementation - Pipeline Products by Stage of Development
Figure 2: Viscosupplementation - Pipeline Products by Segment
Figure 3: Viscosupplementation - Pipeline Products by Territory
Figure 4: Viscosupplementation - Pipeline Products by Regulatory Path
Figure 5: Viscosupplementation - Pipeline Products by Estimated Approval Date
Figure 6: Viscosupplementation - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 3
  • Ampio Pharmaceuticals Inc
  • Anika Therapeutics Inc
  • Carticept Medical Inc
  • Chi2Gel Ltd.
  • Cocoon Biotech, Inc.
  • Flex Biomedical Inc
  • Herng Shan Co Ltd
  • Kalvista Pharmaceuticals Inc
  • KiOmed Pharma
  • Lineage Cell Therapeutics Inc
  • Medytox Inc
  • Moebius Medical Ltd
  • OPKO Health Inc
  • Shin Poong Pharm Co Ltd
  • University of Kansas
Note: Product cover images may vary from those shown
Adroll
adroll